Fig 2 - by Yu Xiong (1478806)

Alteration of Fractional Anisotropy and Mean Diffusivity in Glaucoma: Novel Results of a Meta-Analysis of Diffusion Tensor Imaging Studies by Ke Li (106849)

“…Stata was used to analyze the decrease in fractional anisotropy (FA) and increase in mean diffusivity (MD) in the optic nerve and optic radiation in patients with glaucoma.…”

Effect of inhaled AZLI on standard variables pre and post treatment. by Silvia M. Caceres (12506230)

“…Gram negative organisms showed a significant decrease post treatment (p = 0.02, paired t-test following log transformation). …”

Parameter estimates of linear mixed effects models for juvenile <i>M</i>. <i>mercenaria</i>, juvenile <i>M</i>. <i>arenaria</i> and juvenile <i>A</i>. <i>islandica</i> mean shell c... by Teagan McMahon (20108036)

Multiple agents are able to induce CLL B cell differentiation and subsequent decrease in LEF-1 expression. by Albert Gutierrez Jr. (342562)

Renal outcomes of both treatment groups. by Marwan El-Deyarbi (21688492)

“…</p><p>Results</p><p>During a mean follow-up of 11.9 months, 40.4% of the participants in the intervention group (31.6% in the control group) achieved diabetes control (HbA1c < 7%), with a significant mean difference of −0.36% in HbA1c levels between the groups (95% CI: −0.54 – −0.19, P < 0.01). …”

Comparing A) ROS and B) GSH levels in COCs versus DOs recovered from PMSG-stimulated NMRI mice cultured in absence or presence of 0.5 µM PA during IVM. Data are presented as means... by Shahrzad Ronasi (20933556)

A. The difference in mean value of AT1 measured preoperative, after lenticule creation, and after lenticule extraction during SMILE. by Yang Shen (66591)

Time-dependent and rapid decrease in Cx43 protein levels in ethanol-treated HL-1 cells. by Kanako Noritake (790002)

Vasodilator capacity to decrease maximal hypoxic mPAP and AUC_SaO2. by Eva Maria Becker (451197)

“…<p>Vasodilator capacity to decrease maximal hypoxic mPAP (positive treatment effect) and AUC_SaO2 (unwanted desaturation effect) based on (A) pooled effects at all dose levels tested (N = 6, four doses per group) and (B) at each drug's maximal effective dose (i.e., cumulative dose) (mean ± SEM, N = 6, doses as indicated). …”

Effects of OXA on fasting blood glucose. by Weiran Ye (2552146)

Effects of OXA on body weight gain. by Weiran Ye (2552146)

Quantifying the Contribution of Statins to the Decline in Population Mean Cholesterol by Socioeconomic Group in England 1991 - 2012: A Modelling Study by Chris Kypridemos (719751)

“…In our ‘no statins’ scenario we predicted a mean total cholesterol of 5.36 mmol/L (95% CI: 5.33-5.40) for 2011-12. …”

Effects of OXA on food intake. by Weiran Ye (2552146)

Effects of OXA on fasting serum insulin levels. by Weiran Ye (2552146)

αENaC and S protein compete for furin-mediated cleavage in a cellular system. by Germán Ricardo Magaña-Ávila (18446799)

Serum VEGF-D levels are elevated at baseline, decrease with sirolimus treatment, and correlate with kidney angiomyolipoma size. by Sandra L. Dabora (206838)

“…According to other studies <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0023379#pone.0023379-Glasgow1" target="_blank">[39]</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0023379#pone.0023379-Young1" target="_blank">[41]</a>, mean serum VEGF-D levels in control female populations are 300–657 ng/ml (indicated by gray box, see additional details in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0023379#pone.0023379.s013" target="_blank">Table S4</a>, mean VEGF-D levels in control males is not available). …”

Effect of cilostazol on the serum ALT (A), AST (B) levels in rats with TAA-induced liver fibrosis. by Sally A. El Awdan (710176)

Effect of cilostazol on liver α-SMA (A) and COL-1 (B) in TAA-induced fibrosis in rats. by Sally A. El Awdan (710176)

Effects of OXA on serum HbA1c levels. by Weiran Ye (2552146)